Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years

Why did Bitcoin hit a new all-time high? How will Trump’s tax bill affect clean energy stocks? What caused Walmart to announce large corporate layoffs? Why is the Supreme Court protecting the Federal Reserve? How did BYD outsell Tesla in Europe? What’s driving the rise in U.S. Treasury yields? Why is Harvard blocked from enrolling international students? How will stablecoin joint efforts by big banks impact crypto? What explains the surge in semiconductor stocks partnered with Nvidia?

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years

benzinga.com/insights/news/25/05/45577206/heres-how-much-you-would-have-made-owning-regeneron-pharmaceuticals-stock-in-the-last-15-years

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years by 10.66% on an annualized basis producing an average annual return of 22.46%. Currently, Regeneron Pharmaceuticals has a market capitalization of $64.44 billion.
Buying $100 In REGN: If ...
Full…

This story appeared on benzinga.com, 2025-05-22 21:45:20.